Selected
Healthy Cities

Fetosense

AI-powered antenatal care to ensure safer pregnancies

Team Leader
Ameya Bondre
AI based fetal heart monitoring to reduce prematurity in low and middle income countries

Solution Pitch

The Problem

In India alone, there are more than five million high-risk pregnancies every year. Studies show that regular antenatal care can reduce neonatal death and disease. However, frontline health workers in India can only provide 21 percent of antenatal care coverage, and routine fetal monitoring is limited, which contributes to 600,000 stillbirths and 3.5 million premature babies born every year. 

The Solution

To expand access to antenatal care, CareMother built a mobile care program that provides home-based and center-based antenatal tests. In this program, frontline health workers use Fetosense, a wireless, portable fetal heart monitor that uses machine learning to predict fetal health outcomes.

Fetosense is easy to use—health workers simply place a belt on the mother’s abdomen and start the device. With Fetosense, frontline health workers run tests, read results, and transfer data to doctors in real time—enabling remote monitoring by gynecologists. Through this system, health workers can make informed decisions and refer mothers for timely intervention, improving neonatal outcomes. 

Market Opportunity

CareMother’s total addressable market size in five years is $1 billion, covering 3 million pregnancies in India. The priority market segment is gynaecologists and general physicians and health workers, who serve 30 million pregnancies per year. CareMother will establish annual contracts with local municipal governments or public hospitals for a revenue sharing model with a minimum of 500 tests and 10 percent subscription fees.

Partnership Goals

CareMother currently seeks:

  • Consultation on a referral strategy for revenue generation with medical specialists;
  • Advice on scaling up strategy, including staffing, technology, operations, and supply chain; and
  • Scoping opportunities to implement AI capabilities into the CareMother platform to enhance decision support.

Organization Highlights

Some of CareMother’s notable achievements include:

  • Media coverage in CNBC, Forbes, The Better India, and Mumbai Mirror; and
  • Participation in a range of accelerators: Google Launchpad Accelerator; Miller Center for Social Entrepreneurship, Santa Clara University; Grand Challenges Canada, Transition to Scale; and Skoll World Forum on Social Entrepreneurship.

Existing Partnerships

CareMother currently partners with the Federation of Obstetric and Gynecological Societies of India (FOGSI) to support scale-up and outreach to gynaecologists as well as physician and nurse cadres.

What is the name of your organization?
CareNX Innovations
What is the name of your solution?
Fetosense
Provide a one-line summary or tagline for your solution.
AI based fetal heart monitoring to reduce prematurity in low and middle income countries
In what city, town, or region is your solution team headquartered?
Mumbai
In what country is your solution team headquartered?
India
What type of organization is your solution team?
For-Profit
Film your elevator pitch.
What specific problem are you solving?
In many low- and middle-income countries (LMICs), over 80% of pregnant women receive antenatal care at primary facilities that lack fetal monitoring. Specialists are concentrated in urban hospitals, so fetal distress is often missed, causing delayed care, unnecessary referrals, and higher NICU admissions.
What is your solution?
Fetosense is a digital fetal monitoring platform developed by CareNX Innovations that enables specialist-quality fetal assessment at the primary healthcare level. It combines a portable cardiotocography (CTG) device with mobile connectivity, cloud-based telemonitoring, and an AI-powered decision-support system. Fetosense allows general physicians, nurses, and midwives to screen for fetal distress and remotely escalate high-risk cases to specialists. Designed for low-resource environments, the platform integrates into existing antenatal care and referral workflows, supports interoperability through FHIR-compatible APIs, and aligns with WHO digital health principles. Fetosense is being further enhanced through a UNICEF Venture Fund collaboration to develop an open-source AI module for broader global adoption.
Who does your solution serve, and in what ways will the solution impact their lives?
Fetosense serves pregnant women in low-resource and underserved settings, particularly those receiving care at primary health centers without regular access to specialists. By enabling early detection of fetal distress and timely referrals, the solution improves maternal and neonatal outcomes and reduces preventable complications. Fetosense also empowers frontline healthcare providers—general physicians, nurses, and midwives—by providing actionable clinical insights and remote specialist support. Health systems benefit through reduced unnecessary referrals, lower NICU admissions, and more efficient use of specialist resources. To date, Fetosense has screened over 500,000 pregnancies and reduced NICU admissions by more than 30%.

Stats

CareMother has served 35,000+ pregnancies via 260 frontline health workers from nine different states of India.

Fetosense is used across 20+ hospitals and has already completed 1,000+ assessments.

Solver Team

Organization Type:
For Profit

Headquarters:
Mumbai, India

Stage:
Growth

Working in:
India

Employees:
23

Website:
https://caremother.in/

Solution Team:
Ameya Bondre
Ameya Bondre
Head of Clinical Research and Development